Does ALTEPLASE Cause Pericardial effusion? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Pericardial effusion have been filed in association with ALTEPLASE (Activase). This represents 0.2% of all adverse event reports for ALTEPLASE.
22
Reports of Pericardial effusion with ALTEPLASE
0.2%
of all ALTEPLASE reports
10
Deaths
9
Hospitalizations
How Dangerous Is Pericardial effusion From ALTEPLASE?
Of the 22 reports, 10 (45.5%) resulted in death, 9 (40.9%) required hospitalization, and 2 (9.1%) were considered life-threatening.
Is Pericardial effusion Listed in the Official Label?
Yes, Pericardial effusion is listed as a known adverse reaction in the official FDA drug label for ALTEPLASE.
What Other Side Effects Does ALTEPLASE Cause?
No adverse event (2,456)
Off label use (1,752)
Gingival bleeding (1,018)
Cerebral haemorrhage (819)
Death (818)
Haemorrhage intracranial (615)
Angioedema (603)
Haemorrhage (536)
Drug ineffective (524)
Haemorrhagic transformation stroke (496)
What Other Drugs Cause Pericardial effusion?
TREPROSTINIL (584)
IBRUTINIB (467)
CYCLOPHOSPHAMIDE (458)
NIVOLUMAB (454)
METHOTREXATE (412)
MACITENTAN (407)
DASATINIB (388)
ADALIMUMAB (374)
AMBRISENTAN (371)
PEMBROLIZUMAB (362)
Which ALTEPLASE Alternatives Have Lower Pericardial effusion Risk?
ALTEPLASE vs ALTERNARIA ALTERNATA
ALTEPLASE vs ALTHIAZIDE
ALTEPLASE vs ALTHIAZIDE\SPIRONOLACTONE
ALTEPLASE vs ALUMINUM
ALTEPLASE vs ALUMINUM HYDROXIDE